MedCap (OM:MCAP) - Aandelenkoers, Nieuws & Analyse

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

MCAP Overzicht aandelen

MCAP fundamentele analyse
Sneeuwvlok Score
Waardering	4/6
Toekomstige groei	0/6
Prestaties in het verleden	5/6
Financiële gezondheid	6/6
Dividenden	0/6

Beloningen

Verhandeld tegen 51.7% onder onze schatting van de reële waarde

De winst groeide het afgelopen jaar met 43.7%

Risicoanalyse

MCAP onze risicocontroles hebben doorstaan.

MedCap AB (publ) Concurrenten

Biotage

OM:BIOT

SEK 14.8b

AddLife

OM:ALIF B

SEK 19.5b

Genovis AB (publ.)

OM:GENO

SEK 1.7b

Magle Chemoswed Holding

OM:MAGLE

SEK 434.2m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor MedCap
Historische aandelenkoersen
Huidige aandelenkoers	SEK 487.50
52 Week Hoogtepunt	SEK 624.00
52 Week Laag	SEK 247.00
Bèta	0.72
11 maand verandering	-5.16%
3 maanden verandering	-6.07%
1 Jaar Verandering	83.62%
33 jaar verandering	160.97%
5 jaar verandering	263.81%
Verandering sinds IPO	4,726.73%

Recent nieuws en updates

Estimating The Intrinsic Value Of MedCap AB (publ) (STO:MCAP)

Jun 06

Recent updates

Estimating The Intrinsic Value Of MedCap AB (publ) (STO:MCAP)

Jun 06

MedCap AB (publ) (STO:MCAP) Stocks Shoot Up 33% But Its P/E Still Looks Reasonable

May 21

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

May 04

MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Feb 15

Declining Stock and Solid Fundamentals: Is The Market Wrong About MedCap AB (publ) (STO:MCAP)?

Jan 22

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Jan 07

MedCap (STO:MCAP) Is Growing Earnings But Are They A Good Guide?

Dec 22

If You Had Bought MedCap (STO:MCAP) Stock Five Years Ago, You Could Pocket A 663% Gain Today

Dec 08

Are Insiders Selling MedCap AB (publ) (STO:MCAP) Stock?

Nov 23

Rendement voor aandeelhouders

	MCAP	SE Life Sciences	SE Markt
7D	-1.9%	2.8%	0.8%
1Y	83.6%	82.7%	25.1%

Rendement versus industrie: MCAP kwam overeen met de Swedish Life Sciences industrie, die het afgelopen jaar een rendement opleverde van 82.7 %.

Rendement versus markt: MCAP overtrof de Swedish markt, die het afgelopen jaar een rendement opleverde van 24.5 %.

Prijsvolatiliteit

Is MCAP's price volatile compared to industry and market?
MCAP volatility
MCAP Average Weekly Movement	6.4%
Life Sciences Industry Average Movement	8.4%
Market Average Movement	5.5%
10% most volatile stocks in SE Market	11.6%
10% least volatile stocks in SE Market	3.2%

Stabiele aandelenkoers: MCAP heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 6% ) van MCAP is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2001	530	Anders Dahlberg	medcap.se/en/

MedCap AB (publ) is een participatiemaatschappij die gespecialiseerd is in investeringen in secundaire directe, latere fasen, consolidatie in de sector, add-on overnames, groeikapitaal, middenmarkt, volwassen, turnarounds en buy-outs. Het bedrijf investeert bij voorkeur in apparatuur en diensten voor de gezondheidszorg, biotechnologie, biowetenschappen, farmaceutica, medische technologie en ondersteunende technologiebedrijven. Het bedrijf investeert bij voorkeur in kleine tot middelgrote bedrijven die niet beursgenoteerd zijn en gevestigd zijn in Scandinavië en Noord-Europa.

MedCap AB (publ) Samenvatting

Hoe verhouden de winst en inkomsten van MedCap zich tot de beurswaarde?
MCAP fundamentele statistieken
Marktkapitalisatie	SEK 7.22b
Inkomsten(TTM)	SEK 213.50m
Inkomsten(TTM)	SEK 1.75b

33.8x

Koers/Winstverhouding

4.1x

P/S-verhouding

Is MCAP overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
MCAP resultatenrekening (TTM)
Inkomsten	SEK 1.75b
Kosten van inkomsten	SEK 709.00m
Brutowinst	SEK 1.04b
Overige uitgaven	SEK 830.30m
Inkomsten	SEK 213.50m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

Oct 25, 2024

Winst per aandeel (EPS)	14.42
Brutomarge	59.55%
Nettowinstmarge	12.18%
Schuld/Eigen Vermogen Verhouding	8.2%

Hoe presteerde MCAP op de lange termijn?

Bekijk historische prestaties en vergelijking

MCAP Overzicht aandelen

Beloningen

Risicoanalyse

MedCap AB (publ) Concurrenten

OM:BIOT

SEK 14.8b

OM:ALIF B

SEK 19.5b

OM:GENO

SEK 1.7b

OM:MAGLE

SEK 434.2m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Chief Executive Officer recently bought kr265k worth of stock

Second quarter 2024 earnings released: EPS: kr3.84 (vs kr3.16 in 2Q 2023)

MedCap AB (publ) to Report Q2, 2025 Results on Jul 23, 2025

Now 17% undervalued

Now 21% undervalued

Estimating The Intrinsic Value Of MedCap AB (publ) (STO:MCAP)

Recent updates

Chief Executive Officer recently bought kr265k worth of stock

Second quarter 2024 earnings released: EPS: kr3.84 (vs kr3.16 in 2Q 2023)

MedCap AB (publ) to Report Q2, 2025 Results on Jul 23, 2025

Now 17% undervalued

Now 21% undervalued

Estimating The Intrinsic Value Of MedCap AB (publ) (STO:MCAP)

MedCap AB (publ) (STO:MCAP) Stocks Shoot Up 33% But Its P/E Still Looks Reasonable

Now 21% undervalued

MedCap AB (publ) to Report Q1, 2025 Results on Apr 29, 2025

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

First quarter 2024 earnings released: EPS: kr3.78 (vs kr1.68 in 1Q 2023)

MedCap AB (publ), Annual General Meeting, May 06, 2024

MedCap AB (publ) to Report Fiscal Year 2024 Results on Jan 31, 2025

MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Full year 2023 earnings released: EPS: kr11.63 (vs kr7.94 in FY 2022)

Investor sentiment improves as stock rises 19%

Is Now The Time To Put MedCap (STO:MCAP) On Your Watchlist?

MedCap AB (publ) to Report Q3, 2024 Results on Oct 25, 2024

Third quarter 2023 earnings released: EPS: kr2.59 (vs kr2.47 in 3Q 2022)

MedCap AB (publ) to Report First Half, 2024 Results on Jul 19, 2024

Second quarter 2023 earnings released: EPS: kr3.16 (vs kr1.42 in 2Q 2022)

MedCap AB (publ) (OM:MCAP) signed an agreement to acquire SurgiCube International B.V. for €8 million.

Do MedCap's (STO:MCAP) Earnings Warrant Your Attention?

MedCap AB (publ) to Report Q1, 2024 Results on May 03, 2024

First quarter 2023 earnings released: EPS: kr1.68 (vs kr1.32 in 1Q 2022)

Full year 2022 earnings released: EPS: kr7.94 (vs kr6.52 in FY 2021)

These 4 Measures Indicate That MedCap (STO:MCAP) Is Using Debt Safely

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: kr2.47 (vs kr1.73 in 3Q 2021)

We Ran A Stock Scan For Earnings Growth And MedCap (STO:MCAP) Passed With Ease

Now 21% undervalued

Now 21% undervalued

MedCap AB (publ) to Report Q2, 2023 Results on Jul 28, 2023

High number of new and inexperienced directors

MedCap AB (publ) to Report Q2, 2023 Results on Jul 28, 2023

MedCap AB (publ) to Report Q3, 2022 Results on Oct 28, 2022

High number of new and inexperienced directors

MedCap AB (publ) to Report Q1, 2023 Results on May 03, 2023

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Does MedCap (STO:MCAP) Deserve A Spot On Your Watchlist?

MedCap AB (publ) to Report Q4, 2022 Results on Feb 10, 2023

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

MedCap (STO:MCAP) Seems To Use Debt Rather Sparingly

Investor sentiment improved over the past week

Now 22% undervalued after recent price drop

High number of new directors

Chief Executive Officer recently bought kr348k worth of stock

Investment Manager recently bought kr828k worth of stock

Third quarter 2021 earnings released: EPS kr1.73 (vs kr0.89 in 3Q 2020)

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Second quarter 2021 earnings released: EPS kr1.06 (vs kr1.33 in 2Q 2020)

Does MedCap (STO:MCAP) Have A Healthy Balance Sheet?

Investor sentiment deteriorated over the past week

Independent Chairman of the Board recently bought kr1.1m worth of stock

Here's Why I Think MedCap (STO:MCAP) Is An Interesting Stock

Imagine Holding MedCap (STO:MCAP) Shares While The Price Zoomed 558% Higher

Have Insiders Been Selling MedCap AB (publ) (STO:MCAP) Shares?

Revenue and earnings beat expectations

Full year 2020 earnings released: EPS kr4.36 (vs kr4.10 in FY 2019)